Monte Rosa Therapeutics Inc - GLUE - stock price prediction, stock price target, analyst ratings from 8 analysts

Monte Rosa Therapeutics Inc has a share price target of US$ 28, revenue growth forecast of -46.7%, and profit growth estimate of -293.3% for FY26, based on top 8 analyst calls.